Cargando…
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis
Background: Cardiovascular (CV) morbidity, mortality and metabolic syndrome are associated with rheumatoid arthritis (RA). A recent trial has suggested increased risk of major CV events (MACE) upon the Janus kinase (JAK) inhibitor tofacitinib compared with anti-tumor necrosis factor α (TNF-α) therap...
Autores principales: | Czókolyová, Monika, Hamar, Attila, Pusztai, Anita, Tajti, Gábor, Végh, Edit, Pethő, Zsófia, Bodnár, Nóra, Horváth, Ágnes, Soós, Boglárka, Szamosi, Szilvia, Szentpéteri, Anita, Seres, Ildikó, Harangi, Mariann, Paragh, György, Kerekes, György, Bodoki, Levente, Domján, Andrea, Hodosi, Katalin, Seres, Tamás, Panyi, György, Szekanecz, Zoltán, Szűcs, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599623/ https://www.ncbi.nlm.nih.gov/pubmed/36291691 http://dx.doi.org/10.3390/biom12101483 |
Ejemplares similares
-
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis
por: Kerekes, György, et al.
Publicado: (2023) -
Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology
por: Czókolyová, Monika, et al.
Publicado: (2021) -
Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status
por: Hamar, Attila, et al.
Publicado: (2021) -
Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach
por: Soós, Boglárka, et al.
Publicado: (2022) -
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis
por: Kacsándi, Dorottya, et al.
Publicado: (2023)